137 related articles for article (PubMed ID: 16769725)
1. The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells.
García-Pedrero JM; Kiskinis E; Parker MG; Belandia B
J Biol Chem; 2006 Aug; 281(32):22656-64. PubMed ID: 16769725
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient.
Villaronga MA; López-Mateo I; Markert L; Espinosa E; Fresno Vara JA; Belandia B
Breast Cancer Res Treat; 2011 Aug; 128(3):891-8. PubMed ID: 21465167
[TBL] [Abstract][Full Text] [Related]
3. Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
Link KA; Balasubramaniam S; Sharma A; Comstock CE; Godoy-Tundidor S; Powers N; Cao KH; Haelens A; Claessens F; Revelo MP; Knudsen KE
Cancer Res; 2008 Jun; 68(12):4551-8. PubMed ID: 18559499
[TBL] [Abstract][Full Text] [Related]
4. Identification of BAF57 mutations in human breast cancer cell lines.
Kiskinis E; García-Pedrero JM; Villaronga MA; Parker MG; Belandia B
Breast Cancer Res Treat; 2006 Jul; 98(2):191-8. PubMed ID: 16538531
[TBL] [Abstract][Full Text] [Related]
5. Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes.
Belandia B; Orford RL; Hurst HC; Parker MG
EMBO J; 2002 Aug; 21(15):4094-103. PubMed ID: 12145209
[TBL] [Abstract][Full Text] [Related]
6. A role for BAF57 in cell cycle-dependent transcriptional regulation by the SWI/SNF chromatin remodeling complex.
Hah N; Kolkman A; Ruhl DD; Pijnappel WW; Heck AJ; Timmers HT; Kraus WL
Cancer Res; 2010 Jun; 70(11):4402-11. PubMed ID: 20460533
[TBL] [Abstract][Full Text] [Related]
7. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
[TBL] [Abstract][Full Text] [Related]
8. BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF.
Link KA; Burd CJ; Williams E; Marshall T; Rosson G; Henry E; Weissman B; Knudsen KE
Mol Cell Biol; 2005 Mar; 25(6):2200-15. PubMed ID: 15743818
[TBL] [Abstract][Full Text] [Related]
9. The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene.
Wang L; Baiocchi RA; Pal S; Mosialos G; Caligiuri M; Sif S
Mol Cell Biol; 2005 Sep; 25(18):7953-65. PubMed ID: 16135788
[TBL] [Abstract][Full Text] [Related]
10. BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription.
Harte MT; O'Brien GJ; Ryan NM; Gorski JJ; Savage KI; Crawford NT; Mullan PB; Harkin DP
Cancer Res; 2010 Mar; 70(6):2538-47. PubMed ID: 20215511
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of the SWI/SNF chromatin remodeling complex to steroid hormone-regulated promoters by nuclear receptor coactivator flightless-I.
Jeong KW; Lee YH; Stallcup MR
J Biol Chem; 2009 Oct; 284(43):29298-309. PubMed ID: 19720835
[TBL] [Abstract][Full Text] [Related]
12. Regulating SWI/SNF subunit levels via protein-protein interactions and proteasomal degradation: BAF155 and BAF170 limit expression of BAF57.
Chen J; Archer TK
Mol Cell Biol; 2005 Oct; 25(20):9016-27. PubMed ID: 16199878
[TBL] [Abstract][Full Text] [Related]
13. The developmental and pathogenic roles of BAF57, a special subunit of the BAF chromatin-remodeling complex.
Lomelí H; Castillo-Robles J
FEBS Lett; 2016 Jun; 590(11):1555-69. PubMed ID: 27149204
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the HMG domain of human BAF57 and its interaction with four-way junction DNA.
Heo Y; Park JH; Kim J; Han J; Yun JH; Lee W
Biochem Biophys Res Commun; 2020 Dec; 533(4):919-924. PubMed ID: 33010889
[TBL] [Abstract][Full Text] [Related]
15. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway.
Sethuraman A; Brown M; Seagroves TN; Wu ZH; Pfeffer LM; Fan M
Breast Cancer Res; 2016 Aug; 18(1):81. PubMed ID: 27495308
[TBL] [Abstract][Full Text] [Related]
16. Aberrant BAF57 signaling facilitates prometastatic phenotypes.
Balasubramaniam S; Comstock CE; Ertel A; Jeong KW; Stallcup MR; Addya S; McCue PA; Ostrander WF; Augello MA; Knudsen KE
Clin Cancer Res; 2013 May; 19(10):2657-67. PubMed ID: 23493350
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
[TBL] [Abstract][Full Text] [Related]
18. Expression of BAF57 in ovarian cancer cells and drug sensitivity.
Yamaguchi T; Kurita T; Nishio K; Tsukada J; Hachisuga T; Morimoto Y; Iwai Y; Izumi H
Cancer Sci; 2015 Apr; 106(4):359-66. PubMed ID: 25611552
[TBL] [Abstract][Full Text] [Related]
19. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development.
Kawazu M; Saso K; Tong KI; McQuire T; Goto K; Son DO; Wakeham A; Miyagishi M; Mak TW; Okada H
PLoS One; 2011 Mar; 6(3):e17830. PubMed ID: 21445275
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
Keeton EK; Brown M
Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
